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Abstract  31 
The NRPS/PKS cluster encodes the enzymes necessary for glidobactin synthesis it is 32 
partially conserved in various members of the Burkholderia genus including B. 33 
pseudomallei. In this study we have shown that the insertional inactivation or deletion of 34 
glbC in this cluster in B. pseudomallei could reduce the ability of the bacterium to 35 
survive or grow in murine macrophages or in human neutrophils. Exogenously added 36 
proteasome inhibitors were able to chemically complement the mutation. The insertional 37 
inactivation or deletion of glbC increased virulence in an acute model of infection in 38 
Balb/c or C57BL/6 mice but virulence in a chronic model of infection was similar to that 39 
of the wild type. Our findings contrast with the previous finding that inactivation of the 40 
glb gene cluster in B. pseudomallei strain 1026b resulted in marked attenuation, and 41 
provides evidence of differential roles for some genes in virulence of different strains of 42 
B. pseudomallei. 43 
 44 
keywords; Burkholderia, melioidosis, proteasome 45 
 46 
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 54 
1. Introduction 55 
Non-ribosomal peptides and polyketides are natural products with complex chemical 56 
structures which are synthesized on modular non-ribosomal peptide synthetase (NRPS) 57 
and polyketide synthase (PKS) enzyme complexes. Although NRPS/PKS clusters are 58 
found in all three domains of life, they are most abundant in bacteria (Wang et al., 59 
2014). Many naturally occurring NRPS/PKS products are either exploited as drugs or 60 
are the basis for drug development. These drugs include numerous antibiotics, 61 
immunosuppressive compounds and anticancer agents (Felnagle et al., 2008).  62 
 63 
The role of NRPS/PKS clusters in virulence of bacterial pathogens is much less clear. 64 
There are some examples of their role in the virulence of plant and insect pathogens. 65 
For example, Groll et al. have shown that syringolin, a low molecular weight proteasome 66 
inhibitor, plays a role in virulence of Pseudomonas syringae in bean plants (Groll et al., 67 
2008). However, in mammalian pathogens the only well documented roles are in the 68 
production of low molecular weight iron chelators such as malleilactone, enterobactin, 69 
yersiniabactin and mycobactin (Miethke & Marahiel, 2007, Biggins et al., 2012).  Against 70 
this background, there has been recent interest in establishing whether NRPS/PKS 71 
clusters might contribute to virulence of mammalian pathogens, beyond iron acquisition. 72 
One starting point for these studies is to investigate gene clusters in mammalian 73 
pathogens which are homologues of the clusters in plant pathogens and already shown 74 
to play roles in plant disease. 75 
 76 
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The synthesis of syringolin is directed by a non-ribosomal peptide/polyketide synthase 77 
(NRPS/PKS) cluster (Amrein et al., 2004) which encodes proteins with multifunctional 78 
activities. The individual activities of these proteins are each encoded in discrete 79 
domains (Amrein et al., 2004).  The NRPS/PKS cluster encoding the enzymes 80 
necessary for syringolin synthesis is reported to be partially conserved in various 81 
members of the Burkholderia genus, including B. pseudomallei a pathogen of humans 82 
and other mammals (Schellenberg et al., 2007). A study by Biggins et al (2014) has 83 
confirmed that in B. pseudomallei this cluster encodes the enzymes necessary for 84 
glidobactin, which has a structure of a 12-membered ring consisting of two non-85 
proteinogenic amino acids (erythro-4-hydroxy-L-lysine and 4(S)-amino-2(E)-pentenoic 86 
acid). The ring is linked to an L-threonine residue which in turn is acylated by 87 
unsaturated fatty acids. Two forms of the molecule were identified in B. pseudomallei 88 
culture supernatant, which have been termed glidobactin C and deoxyglidobactin C 89 
(Biggins et al., 2014). Glidobactin C is identical to glidobactin A (Schellenberg et al., 90 
2007), previously identified from a soil-borne member of the Burkholderia genus (strain 91 
K481-B101; species unidentified). These molecules are similar, but not identical to 92 
syringolin. Different naming systems have also been used to identify the similar gene 93 
clusters in B. pseudomallei (syrEFGHI) and in Burkholderia strain K481-B101 94 
(glbABCDEFGH).  In strain K481-B101 the GlbC and GlbF proteins are proposed to be 95 
involved in the synthesis of the tripeptide part of glidobactin A and disruption of glbC 96 
has been shown to abolish the production of glidobactin A (Schellenberg et al., 2007). 97 
There is experimental evidence that syringolin and glidobactin bind to and preferentially 98 
target the chymotrypsin- and trypsin-like activities of the proteasome (de Bettignies & 99 
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Coux, 2010). A recent study indicates that B. pseudomallei glidobactin plays a role in 100 
virulence in mice (Biggins et al., 2014). 101 
 102 
In this study we have determined the function of the glidobactin-encoding enzyme 103 
cluster in B. pseudomallei. B. pseudomallei is the etiological agent of melioidosis, a 104 
disease endemic to parts of Southeast Asia and Northern Australia. We have 105 
inactivated a key gene (glbC; BPSS1269) in the NRPS/PKS glb cluster in B. 106 
pseudomallei and determined the effects of the mutation on growth in phagocytes, 107 
intracellular trafficking and virulence in mice. 108 
 109 
 110 
2.  Methods 111 
 112 
2.1 Bacterial strains, plasmids and cell lines  113 
All bacterial strains and plasmids used in this study are listed in Table 1. Bacteria were 114 
grown with aeration in Luria broth (LB) at 37°C unless otherwise stated. The antibiotics 115 
chloramphenicol (Sigma-Aldrich, UK) and gentamicin (Sigma Aldrich, UK) were used at 116 
concentrations of 50µg/ml and 100µg/ml respectively. The cell line J774.1 murine 117 
macrophage were maintained at 37ºC under 5% CO2 atmosphere in Dulbecco’s 118 
modified Eagle medium (DMEM) (Gibco, Life Technologies) supplemented with 10% 119 
heat inactivated fetal bovine serum (Gibco, Life Technologies). Growth curves for 120 
wildtype K96243, and K96243-∆glbC were carried out in M9 minimal media with 121 
aeration at 37ºC for 24 hr. 122 
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 123 
2.2  Mutant construction 124 
An in frame glbC (BPSS1269) deletion mutant (12.711 Kbp) was constructed using the 125 
suicide plasmid pDM4 containing regions homologous to up and downstream regions of 126 
glbC. Briefly, a DNA fragment containing 500bp regions upstream and downstream of 127 
the glbC (BPSS1269) coding region and flanked by SpeI and XbaI restriction enzymes 128 
was commercially synthesised (GENEART, Invitrogen).  The DNA fragment was cloned 129 
into the suicide plasmid pDM4 via its SpeI and XbaI sites. The presence of the DNA 130 
fragments in the resulting plasmid pDM4-∆glbc was confirmed by PCR using primers F1 131 
– 5’- GCGAGCAGATCGCGAAACAC-3’ and R2 – 5’-CTGATCCGCAAGCTGATCTG-132 
3’.The plasmid pDM4-∆glbC was maintained in E. coli DH5α cells and then further 133 
electroporated into E. coli S17 λpir by electroporation. The plasmid pDM4-∆glbc was 134 
selected on LB agar containing 50 µg/ml chloramphenicol. Plasmid pDM4-∆glbC was 135 
conjugated into B. pseudomallei K96243 and gentamicin and chloramphenicol resistant 136 
transconjugants (K96243-pDM4-∆glbC) single crossover mutants selected. Double 137 
crossover (chloramphenicol sensitive) mutants were obtained after growth on salt free 138 
LB agar containing 10% (wt/vol) sucrose. The genotype of the mutants was confirmed 139 
by genome sequencing using an Illumina HiSeq 2500 platform. Sequence data was 140 
aligned against the K96243 reference genomes using the Illumina GA software. The 141 
aligned reads were then visualised using the software program from Galaxy-Zeus 142 
(Giardine et al., 2005, Blankenberg et al., 2010, Goecks et al., 2010). Genomic regions 143 
with no reads were interpreted as missing from the sequenced genome. 144 
 145 
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2.4 Reverse Transcriptase (RT) PCR 146 
RT-PCRs were performed to investigate transcription of the genes in the glb cluster in 147 
K96243-∆glbC. Total bacterial RNA was isolated from stationary phase cultures of wild 148 
type K96243 and the two mutants using Trizol reagent (Invitrogen, Life Technologies) 149 
according to the manufacturer’s instructions. The quality of the RNA was analysed by 150 
carrying out a PCR to determine if there was any residual DNA remaining. Any residual 151 
DNA was treated with DNAse (Promega, Southampton, UK) at 37°C for 1 hr. Following 152 
this, stop buffer (Promega) was added and incubated at 65°C for 10 min. The RNA was 153 
then quantified using NanoDrop™ 1000, (Wilmington, USA) and 200ng/µl was used to 154 
prepare cDNA transcripts using Invitrogen ThermoScriptTM Reverse Transcriptase 155 
according to manufacturer’s instructions with random hexamers (Invitrogen, Paisley, 156 
UK). The resulting cDNA was then used as a template for PCR using Hot Start Taq 157 
(Qiagen) with primers for BPSS 1265 – 1271 (the primers for each of these genes can 158 
be found in in Table S2). The PCR amplification cycle consisted of 15 min at 96°C, 159 
followed by 30 cycles of 1 min at 94°C, 1.5 min at 54°C and 1.5 min at 72°C, and finally 160 
with a single extension time of 7 min at 72°C. For each PCR, a water control in the 161 
presence and absence of RT (negatives), and K96243 DNA (positive) were carried out 162 
to ensure results obtained, were due to cDNA synthesis and not contaminating genomic 163 
DNA or RNA preparation and reagents.  164 
 165 
2.5 Macrophage uptake and intracellular survival assays 166 
B. pseudomallei uptake and survival were quantified using a kanamycin protection 167 
assay. J774.1 murine macrophages were seeded into a 24 well tissue culture plate at a 168 
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concentration of 1 x 105 cells/ml in DMEM and incubated at 37ºC with 5% CO2 for 169 
approximately 16 hr. Overnight cultures of B. pseudomallei were diluted in L-15 medium 170 
and 1 ml added to the cells at a multiplicity of infection (MOI) of 10. After incubation for 171 
2hr at 37ºC, to allow bacterial invasion, the cells were washed 3 times with warm 172 
phosphate buffered saline (PBS) and incubated with fresh L15 medium containing 173 
1mg/ml kanamycin. After 2hr the macrophage cells were held in fresh media containing 174 
250µg/ml kanamycin to supress the growth of extracellular bacteria. At the indicated 175 
times the cells were washed 3 times in warm PBS and lysed with 0.1% (vol/vol) Triton 176 
X-100. Serial dilutions of the cell lysate were plated onto LB agar to determine the 177 
intracellular bacterial cell counts.  178 
 179 
2.6 Neutrophil isolation  180 
Human neutrophils were isolated from heparinised venous blood by 3.0% (w/v) dextran 181 
T-500 sedimentation (Pharmacosmos, 551005004007) and Ficoll-Paque PLUS 182 
centrifugation (Sigma Aldrich, 10771), as previously described by Chanchamroen et al 183 
(Chanchamroen et al., 2009). The purity of isolated cells was generally greater than 184 
95%, as determined by FACS Calibur flow cytometry (Becton Dickinson).  185 
 186 
2.7 Assay of bacterial intracellular survival 187 
Isolation of neutrophils from human blood was carried out as described previously 188 
(Vanaporn et al., 2011). Purified neutrophils from healthy subjects (n=3) were infected 189 
with B. pseudomallei strain K96243 or K96243-∆glbC at an MOI of 10 and incubated for 190 
30 min at 37°C to allow internalisation. Extracellular bacteria were killed by the addition 191 
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of 250 µg/ml kanamycin and further incubation at 37°C for 30 min. At 1, 3 and 6 hours 192 
post infection (hpi) intracellular survival of B. pseudomallei in neutrophils was 193 
determined after host cell lysis and bacterial colony counting. Bacterial numbers were 194 
expressed as percentages of the initial inoculums for individuals. This was calculated by 195 
dividing the number of recovered bacteria by the total number of B. pseudomallei cells 196 
added.  197 
 198 
2.8 Complementation with proteasome inhibitors 199 
J774.1 murine macrophages cells were prepared as described above. L-15 media 200 
(Gibco) were treated with or without N-[N-(N-acetyl-L-leucyl)-L-leucyl]-L-norleucine (alln) 201 
or clasto-Lactacystin β-Lactone (cLβ-L) (Calbiochem, Merck-Millipore) at final 202 
concentrations of 10 and 5µM/ml respectively before wildtype K96243 or K96243::glbC 203 
was added at a MOI of 10. The experiments were carried out in the same way as 204 
described above and the cell lysate at 2, 8 and 10 hr was analysed for intracellular 205 
bacterial cell counts.  206 
 207 
2.9 Animal studies 208 
Female Balb/c or C57BL/6 mice (6-8 week-old; Harlan Laboratories, Bicester, Oxon, 209 
UK) were used throughout the studies. Groups of 8 mice were given free access to food 210 
and water and subjected to a 12 hr light/dark cycle. Mice were challenged under bio-211 
safety level III containment conditions. All animal experiments were performed in 212 
accordance with the guidelines of the Animals (Scientific Procedures) Act of 1986 and 213 
were approved by the local ethical review committee at the London School of Hygiene 214 
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and Tropical Medicine. For each infection, aliquots were thawed from frozen bacteria 215 
stocks and diluted in pyrogen-free saline (PFS). Prior to intranasal (i.n.) infection, mice 216 
were anesthetised intraperitoneally with ketamine (50mg/kg; Ketaset; Fort Dodge 217 
Animal, Iowa, USA) and xylazine (10 mg/kg; Rompur; Bayer, Leverkusen, Germany) 218 
diluted in PFS. Challenge was performed by administering a total volume of 50µl i.n. 219 
containing B. pseudomallei K96243 wild type or K96243-∆glbC mutant. Control 220 
uninfected mice received 50µl of PFS. The animals were observed twice daily for up to 221 
14 days. Humane endpoints were strictly observed and animals deemed incapable of 222 
survival were humanely killed by cervical dislocation. 223 
 224 
2.10 Statistical Analyses 225 
Differences between average values were tested for significance by performing an 226 
unpaired, two-sided Student’s t-test. The levels of significance of the resulting p values 227 
are reported by the following symbols: * = p < 0.05, ** = p < 0.01, *** = p < 0.001, and 228 
n.s. = non-significant. Log-Rank tests of survival data were performed using the 229 
GraphPad Prism software version 5.01 (GraphPad Software, San Diego California 230 
USA). 231 
 232 
 233 
3. Results  234 
3.1 B. pseudomallei glbC plays a role in growth or survival in macrophages 235 
Previous published data shows that the NRPS/PKS cluster encoding glidobactin is 236 
partially conserved in various members of the Burkholderia genus including B. 237 
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pseudomallei (Schellenberg et al., 2007). Figure 1 shows the genetic organisation of the 238 
glb cluster in B. pseudomallei K96243. To establish whether this cluster encodes 239 
enzymes for a proteasome inhibitor we first made a glbC insertional mutant. The mutant 240 
was confirmed by whole genome sequencing which showed the presence of a plasmid 241 
inserted into the glbC only. We compared the behaviour of the wild type and glbC 242 
mutant in J774.1 macrophages. Compared to the wild type the mutant showed reduced 243 
replication in macrophages, which was most pronounced at the latest sampling point 244 
(10 hpi.). The pre-treatment of macrophages with the proteasome inhibitors ALLN or 245 
cLβ-L restored the ability of the mutant to grow in macrophages (Fig. 2).  However, 246 
during repeat studies we found that the differences in the abilities of wild type and 247 
mutant to grow in macrophages were more pronounced in some J774.1 macrophage 248 
sub-cultures than in others;two of the repeats showed reduced intracellular survival of 249 
the mutant compared to wildtype at 8 h but not 10 h. 250 
 251 
3.2 Construction of a glbC deletion mutant 252 
For our subsequent studies we constructed an in frame deletion mutant of the glbC 253 
(BPSS1269) gene (K96243-∆glbC). The deletion of BPSS1269 was confirmed by whole 254 
genome sequencing of the mutant (K96243-∆glbC) which showed the only the glbC had 255 
been deleted. RT-PCR revealed expression of all of the genes in the glb cluster in B. 256 
pseudomallei K96243 (Fig S1). In K96243-∆glbC we could not demonstrate expression 257 
of BPSS1269 (glbC) or BPSS1268 (glbD), which is located downstream of glbC (Figure 258 
1), but we detected similar expression of the genes upstream of glbC (BPSS1270 and 259 
BPSS1270) and the genes downstream of glbD (BPSS1267 and BPSS1266 and 260 
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BPSS1265). Wild type K96243 and K96243-∆glbC grew at similar rates in M9 minimal 261 
media or in LB (data not shown).  262 
 263 
3.3 A ∆glbC mutant shows a growth defect in human neutrophils 264 
Our recent study demonstrated that macroautophagy is essential for killing of 265 
intracellular B. pseudomallei in human neutrophils (Rinchai et al., 2015) and we next 266 
investigated whether deletion of glbC would affect the intracellular survival ability of the 267 
bacteria in human neutrophils.  PMNs were isolated and infected with an MOI of 10 for 268 
1, 3 and 6 hr and intracellular bacteria enumerated. K96243-∆glbC was more 269 
susceptible to bacterial killing by human neutrophils, compared to the wildtype (Fig. 3). 270 
 271 
3.4 B. pseudomallei ∆glbC is more virulent in an acute mouse model of infection  272 
To further investigate the role of glbC in virulence we infected Balb/c or C57BL/6 mice 273 
with B. pseudomallei K96243 or K96243-∆glbC at two different doses. A high dose of 274 
2500 CFU of wildtype B. pseudomallei has previously been shown to cause acute 275 
disease, whereas a lower dose <1000 CFU can lead to chronic infection in mice 276 
(Conejero et al., 2011). In this study we found that Balb/c or C57BL/6 mice challenged 277 
with high doses of B. pseudomallei K96243 survived longer than those infected with 278 
K96243-∆glbC (Fig. 4A and B). At low doses, the survival of wild type and mutant was 279 
similar. At day 45 all surviving mice were culled and B. pseudomallei was readily 280 
isolated from the spleens, lungs or livers of these mice (data not shown). 281 
 282 
Since our experiments indicated that in acute infection models B. pseudomallei K96243-283 
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glbC is more virulent than the wild type, we measured bacterial clearance kinetics (Fig 284 
5). The bacterial burden was significantly higher in the lung, spleen and blood of mice 285 
infected with B. pseudomallei ∆glbC compared to mice infected with wild type B. 286 
pseudomallei K96243.  287 
 288 
Discussion 289 
Gene clusters which have the potential to encode small molecules are frequently 290 
identified in the genome sequences of bacteria (Challis, 2008). A previous study has 291 
shown that in B. pseudomallei the glb enzyme cluster, alternatively termed the syr 292 
cluster, encodes the enzymes for synethsis of glidobactin and deoxyglidobactin (Biggins 293 
et al., 2014), two related compounds which differ in the substitution of lysine or 294 
hydroxylysine in the warhead of the molecule. These compounds are also related to 295 
syringolin A, which has been shown to be a 20S proteasome inhibitor produced by 296 
Pseudomonas syringae (Groll et al., 2008) and glidobactin A which has antifungal 297 
activity and is produced by the soil-borne bacterium Burkholderia K481-B101 298 
(Schellenberg et al., 2007). Within the Burkholderia glb cluster, the glbC gene is 299 
believed to encode the NRPS modules responsible for synthesis of the tripeptide 300 
component of glidobactin (Schellenberg et al., 2007).  The disruption of glbC in 301 
Burkholderia K481-B101 abolished glidobactin A production (Schellenberg et al., 2007). 302 
In this study we have shown that the insertional inactivation or deletion of glbC in B. 303 
pseudomallei markedly reduced the ability of the bacterium to survive or grow in un-304 
activated murine macrophages or in human neutrophils. Exogenously added 305 
proteasome inhibitors were able to chemically complement the mutation. Our results 306 
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confirm that B. pseudomallei glbC plays a key role in the synthesis of a proteasome 307 
inhibitor which is active towards eukaryotic cells. During repeat studies we did see 308 
differences in the replication of bacteria in different sub-cultures of J774 macrophage 309 
cells. Two further repeats showed a reduced intracellular survival of the mutant 310 
compared to wild type at 8 hours but not at 10 hours. This may reflect differences in the 311 
activation state of the cells. This may reflect differences in the activation state of the 312 
cells. 313 
 314 
A previous study has shown that a gene cluster encoding a proteasome inhibitor plays a 315 
role in the virulence of P. syringae in plants (Groll et al., 2008). More recently, a study 316 
conducted by Biggins et al. 2014 found that a mutant of B. pseudomallei strain 1026b, in 317 
which glbB and the 5’ region of glbC were deleted, was completely attenuated in mice 318 
after intranasal challenge (Biggins et al., 2014).  In contrast, we found that a glbC 319 
deletion mutant in strain K96243 showed an increase in virulence in an acute model of 320 
disease in two strains of mice compared to the wild type. We found similar results when 321 
we tested a glbC insertional mutant of K96243 (results not shown). The decreased 322 
intracellular survival and the increased virulence in animal model for the glbC mutant 323 
observed highlights the limitations of using a cell culture system. These results indicate 324 
that the glbC mutant must exhibit different phenotypes in different cell types. It is not 325 
clear why the phenotype of the K96243 glbC mutant we have constructed is different 326 
from the phenotype of the strain 1026b mutant. In both studies Balb/c mice were used 327 
and were challenged by the intranasal route. It is possible that the deletion of glbB in 328 
strain 1026b mutant is responsible for the attenuation seen, and we have shown that 329 
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glbB was expressed in our glbC deletion mutant. The organisation of the glb cluster is 330 
the same in strains K96243 and 1026b. However, we found there to be 52 single length 331 
polymorphisms (SNPs) between the two glbC. A further 5 SNPs between the glbF, 1 332 
SNP in glbB and 0 SNPs between the  glbE and glbD regions of the loci. These SNPs 333 
may contribute to the differences in phenotypes seen between strains K96243 and 334 
1026b including the reduced transcript levels of downstream glbD. Alternatively, the 335 
difference may reflect differences in the biochemistry of strains K96243 and 1026b. It is 336 
interesting to note that a tat mutant of strain K96243 was reported to be essential for 337 
growth under aerobic conditions (Moule et al., 2014, Wagley et al., 2014) but a tat 338 
mutant of strain 1026b grew normally under these conditions (Rholl et al., 2011).  339 
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Fig 1. Organisation of the glidobactin (glb) cluster in B. pseudomallei K96243. The glbC 409 
(BPSS1269) gene was deleted in K96243-∆glbC. Expression of the genes shown in 410 
wild type and mutant was assessed using RT-PCR (see Fig S1 for details).  411 
 412 
Fig 2. Survival of B. pseudomallei K96243 or K96243::glbC in J774.1 macrophages. 413 
Macrophages we infected with wild type or mutant at an MOI of 10 and at 2, 8 and 10hr 414 
the cells were lysed and intracellular bacteria enumerated. In some cases the 415 
proteasome inhibitors ALLN or cLβ-L (10 and 5µM/ml respectively) were added to the 416 
cells before infection. Results shown are the mean of 3 replicates, the error bars 417 
represent the SEM values. 418 
 419 
 420 
Fig 3. Survival of B. pseudomallei K96243 (white bars) or K96243-∆glbC (black bars) in 421 
human neutrophils. Neutrophils from healthy individual (n=3) were infected with B. 422 
pseudomallei strain K96243 or K96243-∆glbC at an MOI of 10. At 1, 3 and 6 hpi 423 
intracellular bacteria were enumerated. * = p<0.05, ** = p< 0.01, using a unpaired t-test. 424 
 425 
Fig 4. Virulence of B. pseudomallei wild type or ∆glbC mutant in mice. Balb/c (A) or 426 
C57BL/6 mice (B) (n=6-8 per group) were infected i.n.with either B. pseudomallei 427 
K96243 or B. pseudomallei  K96243-∆glbC at the doses stated and survival determined. 428 
Stated doses refer to the actual CFU given to each group by CFU counts on the 429 
inoculum used on the day of the experiment. * = p<0.001. 430 
 431 
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Fig. 5. Bacterial clearance kinetics following acute i.n. infection. C57BL/6 mice 432 
(n=5/group) were challenged i.n. with approximately 2000 CFU B. pseudomallei K96243 433 
(actual counts 2150 CFU) or B. pseudomallei K96243-∆glbC (actual counts 3495 CFU). 434 
Organs (A; lung, B; spleen, C; blood) were harvested at day 1 (d1), 2 (d2) or 3 (d3) p.i., 435 
homogenized and plated out on TSA plates.  † = (deaths/total). * = p<0.05, ** = p< 0.01. 436 
 437 
 438 
 439 
 440 
 441 
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Table 1: Bacterial strains and plasmids used in this study 443 
Bacterial Strain Description Source or Reference 
B. pseudomallei strains 
K96243 Clinical isolate from Thailand  Holden et al 2004 
K96243-RFP Reporter plasmid Wand et al 2011 
K96243-∆glbC Inactivation of BPSS1269 
(glbC) by complete deletion 
This study 
K96243:: glbC Inactivation of glb cluster by 
insertional inactivation of 
BPSS1269. cmr 
This study 
E. coli  Strains 
DH5 ∆pir recA1 gyrA (Nal) ∆(lacIZYA-
argF) (ϕ80dlac∆[lacZ]M15) 
pirRK6 
Simon et al 1983 
S17-1 ∆pir RPA-2 tra regulon; 
pirRK6SmrTpr 
Simon et al 1983 
Plasmids 
pDM4 Suicide vector with R6K origin: 
Cmr 
Milton et al 1996 
pDM4 - ∆glbC 500bp up and down stream of 
glbC cloned into pDM4  
This study 
pBHR4-groS-RFP Reporter plasmid -red Wand et al 2011 
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florescent protein 
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Highlights 
1. A NRPS/PKS cluster encoding the enzymes necessary for glidobactin synthesis is partially 
conserved in Burkholderia pseudomallei.  
2. We show that the insertional inactivation or deletion of glbC in this cluster in B. 
pseudomallei could reduce the ability of the bacterium to survive or grow in murine 
macrophages or in human neutrophils.  
3. The addition of proteasome inhibitors to the glbC inactivated mutant chemically 
complemented the mutation.  
4. The insertional inactivation or deletion of glbC increased virulence in an acute model of 
infection in Balb/c or C57BL/6 mice but virulence in a chronic model of infection was similar 
to that of the wild type.  
